Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Gustafson Mark, Director. Director active across 1 company, notably Alzamend Neuro, Inc.. In total, 8 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €123k. Activity tracked since 13 September 2021. The latest transaction was filed on 31 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Mark Gustafson serves as a Board Member at Alzamend Neuro, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the biotechnology sector allows him to provide valuable insights into operations and market challenges. He also ensures that the company adheres to ethical and regulatory standards.